A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
Clinical trial NCT01399580 · COMPLETED
Trial details
- NCT number
- NCT01399580
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-09-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.